Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptors for neuropeptide Y: multiple subtypes and multiple second messengers.

M C Michel1

  • 1Medizinische Klinik Nephrologie, Universitätsklinikum Essen, FRG.

Trends in Pharmacological Sciences
|October 1, 1991
PubMed
Summary

Neuropeptide Y (NPY) receptors mediate physiological effects, but their subtypes and signaling pathways require further research. Developing specific antagonists and cloning studies are essential for precise pharmacological definition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of geriatric patients with benign prostatic hyperplasia].

Der Urologe. Ausg. A·2020
Same author

[Do benign prostatic hyperplasia drugs affect mood or cognition?]

Der Urologe. Ausg. A·2019
Same author

An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational material.

International journal of clinical practice·2014
Same author

The Concise Guide to PHARMACOLOGY 2013/14: overview.

British journal of pharmacology·2014
Same author

Does concomitant diabetes affect treatment responses in overactive bladder patients?

International journal of clinical practice·2013
Same author

Autonomic nervous control of the urinary bladder.

Acta physiologica (Oxford, England)·2012

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Neuropeptide Y (NPY) elicits physiological responses via pre- and postsynaptic receptors.
  • Evidence suggests multiple NPY receptor subtypes exist, based on varying agonist potency across models.

Purpose of the Study:

  • To review the current understanding of Neuropeptide Y (NPY) receptors.
  • To discuss the pharmacological definition, signal transduction, and future research directions for NPY receptors.

Main Methods:

  • Literature review of NPY receptor pharmacology and signal transduction.
  • Analysis of agonist potency data across different model systems.

Main Results:

  • Pharmacological definition of NPY receptor subtypes remains tentative.

Related Experiment Videos

  • NPY receptors couple to signal transduction pathways like adenylyl cyclase inhibition and intracellular Ca2+ modulation.
  • Specific links between NPY receptor subtypes and distinct signaling pathways are not yet established.

    • Conclusions:

    • Further research, including the development of specific antagonists and receptor cloning, is needed to define NPY receptor subtypes.
    • Clarifying the relationship between NPY receptor subtypes and their associated signal transduction mechanisms is crucial.